19-Hydroxyandrost-4-en-3,17-dion

19-Hydroxyandrostenedione

HCID 252379CAS 510-64-5

Grundinformationen

Standard-SMILES
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43CO)[C@@H]1CCC2=O
InChIKey
XGUHPTGEXRHMQQ-BGJMDTOESA-N
Summenformel
C19H26O3
Durchschnittliche Molmasse
302,4 g/mol
Monoisotopische Masse
302,18819469

Namen und Bezeichner

Bevorzugter Name
19-Hydroxyandrostenedione
IUPAC
(8R,9S,10S,13S,14S)-10-(hydroxymethyl)-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
Lokaler Name
19-Hydroxyandrost-4-en-3,17-dion
Englischer Name
19-HYDROXY-4-ANDROSTENE-3,17-DIONE
Summenformel
C19H26O3
Molmasse
302.41

Namen und Synonyme

19-Hydroxyandrost-4-ene-3,17-dione510-64-519-Hydroxy-4-androstene-3,17-dione19-HydroxyandrostenedioneAndrost-4-ene-3,17-dione, 19-hydroxy-NSC-74233A546CQ058419-HAEDJ117.011BCHEBI:27576DTXSID80199007C05290
Weitere Namen anzeigen
19-hydroxy-4-AndrostenedioneNSC 7423NSC 74233Dienogest Impurity 1Hydroxy-4-androsten-3Dienogest Impurity 16
RefChem:437595DTXCID70121498208-116-519-Hydroxyandrostendione4-Androsten-19-ol-3,17-dione(8R,9S,10S,13S,14S)-10-(hydroxymethyl)-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione4-Androstene-3,17-dione-19-ol19-Hydroxyandrost-4-enedione

Datenbank-Bezeichner

CAS
510-64-5、61342-08-3
PubChem CID
252379
ChEMBL
CHEMBL4517318
ChEBI
CHEBI:27576
UNII
A546CQ0584
EC Number
208-116-5
Nikkaji
J117.011B

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1,5
Polarare Oberfläche (TPSA)
54,4 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
1
Schwere Atome
22

Experimentelle und physikochemische Eigenschaften

Physical DescriptionSolid

Physikochemische Eigenschaften

Schmelzpunkt
168 · 168-169 °C(lit.)
Siedepunkt
485.4 · 485.4±45.0 °C(Predicted)
Dichte
1.19 · 1.19±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Sealed in dry,Store in freezer, under -20°C
Löslichkeit
Chloroform (Slightly), Methanol (Slightly)
Aggregatzustand
Solid

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

Danger

H351 (15.2%): Suspected of causing cancer [Warning Carcinogenicity];H360 (15.2%): May damage fertility or the unborn child [Danger Reproductive toxicity];H361 (84.8%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity];H362 (15.2%): May cause harm to breast-fed children [Reproductive toxicity, effects on or via lactation]

P203, P260, P263, P264, P270, P280, P318, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 46 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Hazard Classes and CategoriesCarc. 2 (15.2%);Repr. 1A (15.2%);Repr. 2 (84.8%);Lact. (15.2%)

Sicherheitsdaten

wgk
3
hs_code
29372900
risk_code
36/37/38-63
hazard_code
Xi,Xn
safety_code
22-24/25-36/37/39-27-26-36/37

Chemie und Industrie

Pharmakologische Informationen

Tissue LocationsPlacenta;Testis
Cellular LocationsExtracellular;Membrane
Metabolite Pathways17-Beta Hydroxysteroid Dehydrogenase III Deficiency;Androgen and Estrogen Metabolism;Androstenedione Metabolism;Aromatase deficiency

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Anbieter50 Anbieter

湖北威德利化学试剂有限公司181-6332-1995 18062128043 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
江苏艾康生物医药研发有限公司025-58851090 19370895928 · [email protected]
山东海舟生物工程有限公司130-0567-0367 13006570367 · [email protected]

Zugehörige Reaktionen

51

Verknüpfte Notizen

Wird geladen…